•The FDA is undergoing a strategic reevaluation of its policies under new leadership, prompted by rapid advancements in science and technology. •Now is the time for FDA to pursue a proactive policy ...

Building on the success of the campaign to date, BIO is announcing a new series produced for us by BBC StoryWorks and launching in 2025. In this new iteration, the series will build on the ...

BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

America leads the world in biotechnology innovation, yet the U.S. is the only country where half of every dollar spent on medicine goes to middlemen, hospital markups, and other hidden supply chain ...

Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The ...

Intellectual property is at the center of U.S. biotech leadership. It plays an essential role in the development of lifesaving scientific advances - and the safeguarding of America's national security ...

Here is what you can expect to see and do while attending BIO's Intellectual Property Conference in Palm Springs. Please check back to this page regularly as we get closer to the conference in ...

BIO filed an amicus brief July 19 in the case of Bristol Meyers Squibb and Janssen, who are appealing a decision by the U.S. District Court for the District of New Jersey. The companies argue that the ...

From pandemic preparedness to food security, climate change to resource scarcity, the world requires innovative solutions to the challenges facing society. With its potential to create a diverse and ...

Is this the first time you’re attending BIO International Convention? This webinar is for you! We’ll cover all the basics of where to go and what to do - plus, you’ll get some insider tips from the ...

Thank you for being a member of BIO. Join the conversation and let everyone know you're a member using the resources below!

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...